Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03553498 · ClinicalTrials.gov registry record · Phase 3
IV Acetaminophen as Adjuvant Analgesic to Hydromorphone - Emergency Department Patients
A Phase 3 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 162
- Enrollment target
NCT03553498 is a Phase 3 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 162 participants.
The verdict
NCT03553498, a Phase 3 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 162 participants
- Enrollment target
Study Summary
The goal of this randomized clinical trial is to compare the analgesic efficacy and side effect profile of IV acetaminophen as an analgesic adjunctive medication to IV hydromorphone for the treatment of acute pain experienced by patients in the Emergency Department (ED).
Interventions
- DRUG IV acetaminophen
- DRUG hydromorphone
- DRUG IV placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2019-05-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03553498
The ClinicalTrials.gov registry entry for NCT03553498 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which IV acetaminophen is the first listed.
NCT03553498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03553498 about?
NCT03553498 is a clinical study titled "IV Acetaminophen as Adjuvant Analgesic to Hydromorphone - Emergency Department Patients". The goal of this randomized clinical trial is to compare the analgesic efficacy and side effect profile of IV acetaminophen as an analgesic adjunctive medication to IV hydromorphone for the treatment of acute pain experienced by patients in the Emergency Department (ED).
What is the current status of trial NCT03553498?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 162 participants. The study started on 2018-11-27. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT03553498?
The interventions under investigation include: IV acetaminophen (DRUG), hydromorphone (DRUG), IV placebo (DRUG).
Who is sponsoring clinical trial NCT03553498?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.